Publikationen in Zusammenarbeit mit Forschern von Clínica Universitaria de Navarra (12)

2024

  1. The emerging field of viroimmunotherapy for pediatric brain tumors

    Neuro-oncology, Vol. 26, Núm. 11, pp. 1981-1993

  2. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

    Neuro-Oncology, Vol. 26, Núm. 8, pp. 1509-1525

2022

  1. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

    JCI Insight, Vol. 7, Núm. 7

  2. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

    New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481

2021

  1. Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

    Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820

2019

  1. Oncolytic adenovirus Delta-24-RGD induces a widespread glioma proteotype remodeling during autophagy

    Journal of Proteomics, Vol. 194, pp. 168-178

  2. The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Oncolytic viruses as therapeutic tools for pediatric brain tumors

    Cancers, Vol. 10, Núm. 7

  2. Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection

    Oncotarget, Vol. 9, Núm. 57, pp. 31045-31065

  3. The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma

    Neuro-Oncology, Vol. 20, Núm. 7, pp. 930-941

2017

  1. Development of a DIPG orthotopic model in mice using an implantable guide-screw system

    PLoS ONE, Vol. 12, Núm. 1

  2. Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope

    Journal of Bone Oncology, Vol. 9, pp. 41-47